Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoY
NiveshIQ
NSE: STAR · Healthcare
Strides Pharma Science Ltd.
₹1,036.90▼ ₹31.90 (-2.98%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on STAR. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Strides Pharma Science Ltd.
Strides Pharma Science Limited (STAR) is a diversified Indian pharmaceutical company that designs, manufactures, and markets generic and branded finished dosage forms across multiple therapeutic areas, including anti-infectives, CNS, cardiovascular, and gastroenterology, in markets spanning North America, Europe, Africa, and Asia. In Q2 FY27, the company reported revenue of ₹14,297 million, up 17% YoY, driven largely by a higher share of Ex‑US sales and strong demand for its anti‑infective and pain‑management portfolios. Net income for the quarter stood at ₹617 million, reflecting improved operating efficiency despite margin pressure from raw material costs. Strides maintains a competitive edge through its extensive product pipeline, robust manufacturing capabilities, and a broad geographi
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4,051 Cr +9.83% | ₹4,565 Cr +12.69% | ₹4,859 Cr +6.43% |
| EBITDA Margin | 18.35% | 17.58% | 19.04% |
| Net Profit | -2.10% | ₹3,593 Cr -3953.10% | ₹556.19 Cr -84.52% |
| EPS | ₹-7.76 | ₹390.54 | ₹60.34 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Blue Star BLUESTARCO ICC Award Upheld, WJT Annulment Dismissed
Blue Star (NSE:BLUESTARCO): Why Did Blue Star’s Q2 Revenue Rise While Margins Stayed Under Pressure?
🔒
+ 3 more stories about Strides Pharma Science Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹1, 430 Cr, PAT ₹131 Cr, EPS ₹14.19, EBITDA margin 17.5%. Growth context: revenue YoY +17.1%, PAT YoY +2.6%, revenue QoQ +13.0%, PAT QoQ -16.6%.
Product pipeline execution, domestic demand, export mix, regulatory approvals, and margin discipline are the primary dri...
FY26 (last completed FY): revenue ₹4, 859 Cr, PAT ₹556 Cr, EBITDA margin 19.0%, EPS ₹60.34. Year-on-year: revenue YoY +6...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Rainbow Childrens Medicare Ltd.Rubicon Research Ltd.Sai Life Sciences Ltd.Sanofi India Ltd.Senores Pharmaceuticals Ltd.Shilpa Medicare Ltd.Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.Supriya Lifescience Ltd.Suven Life Sciences Ltd.Syngene International Ltd.Thyrocare Technologies Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for STAR
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track STAR alongside your other holdings
Unlock full STAR research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Strides Pharma Science Ltd.?
NiveshIQ detects active intelligence signals for Strides Pharma Science Ltd. (STAR) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Strides Pharma Science Ltd.?
Strides Pharma Science Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,077,499.0L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.